Evaluating the efficacy of virtual magnetic resonance elastography and continuous-time random walk models in predicting clinically significant prostate cancer
Abdominal Radiology · 04.06.2026 · 51 (12) · 6459-6467
DOI: 10.1007/s00261-026-05549-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Abdominal Radiology, online erschienen am 04.06.2026. Verfasst von Meng Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of MRI, the First Affiliated Hospital of Henan Medical University, Weihui, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Elasticity Imaging Techniques, Magnetic Resonance Imaging. Die Arbeit nennt 35 Literaturangaben. Gefördert von: the 2022 Category B Grant Projects of the Youth Cultivation Fund Program at the First Affiliated Hospital of Xinxiang Medical University, The Key Project of Henan Province Medical Science and Technology Project.
Abstract (Originalsprache)
OBJECTIVE: To evaluate the predictive performance of virtual magnetic resonance elastography (vMRE) and continuous-time random walk (CTRW) models for clinically significant prostate cancer (csPCa, Gleason score ≥ 3 + 4). METHODS: A total of 107 patients with suspected prostate lesions were retrospectively enrolled. Quantitative parameters from vMRE (µ), CTRW (α, β, Dm), conventional DWI (ADC), and clinical indicators were compared between csPCa and non-csPCa groups. Logistic regression was used to identify independent predictors and construct a combined model, with efficacy validated by receiver operating characteristic curve (AUC) and DeLong test. RESULTS: The csPCa group had higher µ, PSAD, PI-RADS, and TPSA, and lower α, β, Dm, and ADC. Multivariate analysis identified µ, α, Dm, and PSAD as independent predictors. The combined model integrating these four parameters yielded the optimal diagnostic performance with an AUC of 0.98, which was significantly superior to single imaging modalities and individual variables, including vMRE (µ), CTRW (α + β + Dm), DWI (ADC), α, β, Dm, PSAD, PI-RADS, and TPSA (AUC = 0.85, 0.92, 0.78, 0.87, 0.74, 0.82, 0.65, 0.84, 0.76, and 0.80, respectively; all P < 0.05). CONCLUSION: Both vMRE and CTRW are superior to conventional DWI in differentiating csPCa. The combined µ + α + Dm + PSAD panel serves as a non-invasive, high-performance biomarker for accurate csPCa prediction, which may help reduce unnecessary prostate biopsies and optimize clinical decision-making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of MRI, the First Affiliated Hospital of Henan Medical University, Weihui, China.
- Department of Orthopedic Surgery, the First Affiliated Hospital of Henan Medical University, Weihui, China.
- Department of MRI, the First Affiliated Hospital of Henan Medical University, Weihui, China. yrf718@163.com.
Förderung
- the 2022 Category B Grant Projects of the Youth Cultivation Fund Program at the First Affiliated Hospital of Xinxiang Medical University
- The Key Project of Henan Province Medical Science and Technology Project
Zitieren
APA
Zhang, M., Zhao, E., Li, X., Li, Z., Duan, J., Qin, R., & Yan, R. (2026). Evaluating the efficacy of virtual magnetic resonance elastography and continuous-time random walk models in predicting clinically significant prostate cancer. Abdominal Radiology, 51(12), 6459-6467. https://doi.org/10.1007/s00261-026-05549-3
Vancouver
Zhang M, Zhao E, Li X, Li Z, Duan J, Qin R, et al. Evaluating the efficacy of virtual magnetic resonance elastography and continuous-time random walk models in predicting clinically significant prostate cancer. Abdominal Radiology. 2026;51(12):6459-6467. doi:10.1007/s00261-026-05549-3
BibTeX
@article{Zhang2026,
author = {Zhang, Meng and Zhao, Endian and Li, Xuekun and Li, Zhong and Duan, Jinhui and Qin, Ruijing and Yan, Ruifang},
title = {Evaluating the efficacy of virtual magnetic resonance elastography and continuous-time random walk models in predicting clinically significant prostate cancer},
journal = {Abdominal Radiology},
year = {2026},
volume = {51},
number = {12},
pages = {6459--6467},
doi = {10.1007/s00261-026-05549-3}
}
EUVIMED